PSAD could distinguish patients with a PSA elevation due to BPH and prostatic inflammation, and it has been proven to improve the accuracy of PI-RADS in the decision to perform prostate biopsies [32]. The gene discussed is KLK3; the disease is benign prostatic hyperplasia.